(19)
(11) EP 1 232 246 A1

(12)

(43) Date of publication:
21.08.2002 Bulletin 2002/34

(21) Application number: 00980623.3

(22) Date of filing: 21.11.2000
(51) International Patent Classification (IPC)7C12N 5/06, C12N 5/08, A61K 39/395, A61P 35/00, A61K 38/17, A61K 47/48, A61K 39/00
// C12Q1:02
(86) International application number:
PCT/US0031/968
(87) International publication number:
WO 0103/8496 (31.05.2001 Gazette 2001/22)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 24.11.1999 US 167394 P
22.12.1999 US 171546 P

(71) Applicant: IMMUNEX CORPORATION
SeattleWashington 98101 (US)

(72) Inventors:
  • GALIBERT, Laurent, J.
    Seattle, WA 98115 (US)
  • BORGES, Luis
    Seattle, WA 98107 (US)

(74) Representative: Cornish, Kristina Victoria Joy et al
Kilburn & Strode,20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)

   


(54) A HUMAN NORMAL COUNTERPART OF CD4+ CD56+ CUTANEOUS NEOPLASM